Adrenergic receptor 3D structures
From Proteopedia
(Difference between revisions)
| Line 4: | Line 4: | ||
{{#tree:id=OrganizedByTopic|openlevels=0| | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
| - | *α- | + | *α-1 adrenergic receptor |
| - | **[[7b6w]] – | + | **[[7b6w]] – hA1BAR + agonist - human<br /> |
| + | **[[7ymj]] – hA1AR + nanobody + tamsulosin – Cryo EM<br /> | ||
| + | **[[8hn1]] – hA1AR + ADTX1 + nanobody – Cryo EM<br /> | ||
| + | **[[8thk]], [[8thl]] – hA1AR/endolysin + Guanine nucleotide binding protein + scFvy – Cryo EM<br /> | ||
| + | **[[7ym8]] – hA1AAR + miniGSQ+ nanobody + oxymetazoline – Cryo EM<br /> | ||
| + | **[[7ymh]] – hA1AAR + miniGSQ+ nanobody + noradernaline – Cryo EM<br /> | ||
*α-2 adrenergic receptor | *α-2 adrenergic receptor | ||
| Line 15: | Line 20: | ||
**[[6kuw]] – hA2ACR + cholesterol + quinolone derivative<br /> | **[[6kuw]] – hA2ACR + cholesterol + quinolone derivative<br /> | ||
**[[6k41]], [[6k42]] – hA2AAR/A2BAR + Gunine nucleotide binding protein + scFv – Cryo EM<br /> | **[[6k41]], [[6k42]] – hA2AAR/A2BAR + Gunine nucleotide binding protein + scFv – Cryo EM<br /> | ||
| + | **[[9cbm]] – hA2AR + Guanine nucleotide binding protein + drug – Cryo EM<br /> | ||
| + | **[[7w6p]], [[7w7e]] – hA2AR + Guanine nucleotide binding protein + scFv + agonist – Cryo EM<br /> | ||
| + | **[[7ym8]] – hA2AR + Guanine nucleotide binding protein + scFv + agonist – Cryo EM<br /> | ||
| + | **[[9cbl]] – hA2AR/endolysin + Guanine nucleotide binding protein + adrenaline + epinephrine – Cryo EM<br /> | ||
**[[7ej0]], [[7ej8]], [[7eja]], [[7ejk]] – hA2AR + Guanine nucleotide binding protein + scFv + drug – Cryo EM<br /> | **[[7ej0]], [[7ej8]], [[7eja]], [[7ejk]] – hA2AR + Guanine nucleotide binding protein + scFv + drug – Cryo EM<br /> | ||
**[[6kux]] – A2AR + antagonist – ''Spodoptera frugiperda''<br /> | **[[6kux]] – A2AR + antagonist – ''Spodoptera frugiperda''<br /> | ||
| Line 20: | Line 29: | ||
*β-1 adrenergic receptor | *β-1 adrenergic receptor | ||
| - | **[[7bts]] – hB1AR/T4 lysozyme (mutant) + nanobody + epinephrine | + | **[[7bts]] – hB1AR/T4 lysozyme (mutant) + nanobody + epinephrine <br /> |
**[[7bu6]], [[7bu7]] – hB1AR/endolysin + nanobody + epinephrine derivative<br /> | **[[7bu6]], [[7bu7]] – hB1AR/endolysin + nanobody + epinephrine derivative<br /> | ||
| + | **[[8dcs]] – hB1AR/endolysin + nanobody + carbonitrile derivative<br /> | ||
**[[7bvq]] – hB1AR/endolysin + carazolol<br /> | **[[7bvq]] – hB1AR/endolysin + carazolol<br /> | ||
**[[2y01]], [[4gpo]], [[5f8u]] – tB1AR fragment (mutant) – turkey<br /> | **[[2y01]], [[4gpo]], [[5f8u]] – tB1AR fragment (mutant) – turkey<br /> | ||
| Line 52: | Line 62: | ||
**[[5jqh]] - hB2AR/T4 lysozyme (mutant) + carazolol + nanobody<br /> | **[[5jqh]] - hB2AR/T4 lysozyme (mutant) + carazolol + nanobody<br /> | ||
**[[3ny8]], [[3ny9]], [[3nya]] – hB2AR/T4 lysozyme + agonist<br /> | **[[3ny8]], [[3ny9]], [[3nya]] – hB2AR/T4 lysozyme + agonist<br /> | ||
| + | **[[7xka]] – hB2AR/endolysin + nanobody + epinephrine <br /> | ||
| + | **[[7xk9]] – hB2AR/endolysin + nanobody + isoproterenol <br /> | ||
| + | **[[8zbe]] – hB2AR /endolysin+ guanine nucleotide-binding protein + scFv + octreotide– Cryo EM<br /> | ||
| + | **[[8jjl]] – hB2AR/cytochrome b562 + agonist – Cryo EM<br /> | ||
| + | **[[8jj8]] – hB2AR/cytochrome b562 + partial agonist – Cryo EM<br /> | ||
| + | **[[8jjo]] – hB2AR/cytochrome b562 + antagonist – Cryo EM<br /> | ||
**[[6n48]] - hB2AR/endolysin + nanobody + modulator<br /> | **[[6n48]] - hB2AR/endolysin + nanobody + modulator<br /> | ||
| - | **[[3sn6]] - | + | **[[3sn6]] - hB2AR + nanobody bound by guanine nucleotide-binding protein G<br /> |
| + | **[[8w1v]] - hB2AR + nanobody + bitopic ligand<br /> | ||
**[[7bz2]], [[7dhi]], [[7dhr]] – hB2AR + guanine nucleotide-binding protein + nanobody + modulator – Cryo EM<br /> | **[[7bz2]], [[7dhi]], [[7dhr]] – hB2AR + guanine nucleotide-binding protein + nanobody + modulator – Cryo EM<br /> | ||
| + | **[[8gdz]], [[8ge1]], [[8ge2]], [[8ge3]], [[8ge4]], [[8ge5]], [[8ge6]], [[8ge7]], [[8ge8]], [[8ge9]], [[8gea]], [[8geb]], [[8gec]], [[8ged]], [[8gee]], [[8gef]], [[8geg]], [[8geh]], [[8gei]], [[8gej]] – hB2AR + guanine nucleotide-binding protein – Cryo EM<br /> | ||
| + | **[[8gfv]], [[8gfw]], [[8gfx]], [[8gfy]], [[8gfz]], [[8gg0]], [[8gg1]], [[8gg2]], [[8gg3]], [[8gg4]], [[8gg5]], [[8gg6]], [[8gg7]], [[8gg8]], [[8gg9]], [[8gga]], [[8ggb]], [[8ggc]], [[8gge]], [[8ggf]], [[8jji]], [[8ggj]], [[8ggk]], [[8ggl]], [[8ggm]], [[8ggn]], [[8ggo]], [[8ggr]], [[8ggs]], [[8ggt]], [[8ggu]], [[8ggw]], [[8ggv]], [[8ggx]], [[8ggy]], [[8ggz]], [[8gh0]], [[8gh1]], [[8unl]], [[8unm]], [[8unn]], [[8ggp]], [[8ggq]], [[8uno]], [[8unp]], [[8unq]], [[8unr]], [[8uns]], [[8unt]], [[8unu]], [[8unv]], [[8unw]], [[8unx]], [[8uny]], [[8unz]], [[8uo0]], [[8uo1]], [[8uo2]], [[8uo3]], [[8uo4]] – hB2AR + guanine nucleotide-binding protein + GTP – Cryo EM<br /> | ||
| + | **[[8zcj]] – hB2AR + guanine nucleotide-binding protein + scFv + cyclic peptide – Cryo EM<br /> | ||
**[[3kj6]], [[2r4r]], [[2r4s]] – hB2AR + FAB heavy+light chains<br /> | **[[3kj6]], [[2r4r]], [[2r4s]] – hB2AR + FAB heavy+light chains<br /> | ||
**[[4qkx]] – B2AR + R9 protein - llama<br /> | **[[4qkx]] – B2AR + R9 protein - llama<br /> | ||
| Line 60: | Line 80: | ||
*β-3 adrenergic receptor | *β-3 adrenergic receptor | ||
| - | **[[7dh5]], [[7xjh]], | + | **[[9ijd]] – hB3AR + guanine nucleotide-binding protein + scFv + VHH + carazolol - Cryo EM<br /> |
| + | **[[9ije]] – hB3AR + guanine nucleotide-binding protein + scFv + VHH + adrenaline + epinephrine - Cryo EM<br /> | ||
| + | **[[7dh5]], [[7xjh]], [[7xji]] – B3AR + guanine nucleotide-binding protein + nanobody + drug – dog - Cryo EM<br /> | ||
}} | }} | ||
[[Category: Topic Page]] | [[Category: Topic Page]] | ||
Revision as of 08:57, 15 September 2024
3D Structures of Adrenergic receptor
Updated on 15-September-2024
